Title : REToma: a cancer subtype with a shared driver oncogene.

Pub. Date : 2020 Apr 22

PMID : 31711124






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RET (REarranged during Transfection), which encodes a receptor tyrosine kinase for members of the glial cell line-derived neurotrophic factor, plays a role as driver oncogene in a variety of human cancers. Tyrosine ret proto-oncogene Homo sapiens
2 Fusion of RET with several partner genes has been detected in papillary thyroid, lung, colorectal, pancreatic, and breast cancers, and tyrosine kinase inhibitors (TKIs) for RET (particularly RET-specific inhibitors) show promising therapeutic effects against such cancers. Tyrosine ret proto-oncogene Homo sapiens
3 Fusion of RET with several partner genes has been detected in papillary thyroid, lung, colorectal, pancreatic, and breast cancers, and tyrosine kinase inhibitors (TKIs) for RET (particularly RET-specific inhibitors) show promising therapeutic effects against such cancers. Tyrosine ret proto-oncogene Homo sapiens
4 Fusion of RET with several partner genes has been detected in papillary thyroid, lung, colorectal, pancreatic, and breast cancers, and tyrosine kinase inhibitors (TKIs) for RET (particularly RET-specific inhibitors) show promising therapeutic effects against such cancers. Tyrosine ret proto-oncogene Homo sapiens